FENC - FENNEC PHARMACEUTICALS INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 9.27

Open

$ 9.26

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 9.18 - $ 9.39

52 Week Range

$ 6.30 - $ 11.92

Volume

38,923

Average Volume

Market Cap

246.34M

Beta (5Y Monthly)

$ 0.74

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-29-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-07-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	03-29-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-30-2021	12-31-2020	10-K
14	11-16-2020	09-30-2020	10-Q
15	08-05-2020	06-30-2020	10-Q
16	05-14-2020	03-31-2020	10-Q
17	02-14-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-09-2019	06-30-2019	10-Q
20	05-10-2019	03-31-2019	10-Q
21	03-15-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-13-2018	06-30-2018	10-Q
24	05-14-2018	03-31-2018	10-Q
25	03-28-2018	12-31-2017	10-K
26	11-13-2017	09-30-2017	10-Q
27	08-14-2017	06-30-2017	10-Q
28	05-12-2017	03-31-2017	10-Q
29	03-29-2017	12-31-2016	10-K
30	11-14-2016	09-30-2016	10-Q
31	08-12-2016	06-30-2016	10-Q
32	05-12-2016	03-31-2016	10-Q
33	03-28-2016	12-31-2015	10-K
34	11-12-2015	09-30-2015	10-Q
35	08-11-2015	06-30-2015	10-Q
36	05-15-2015	03-31-2015	10-Q
37	03-31-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-11-2014	06-30-2014	10-Q
40	05-15-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Fenne...
04/04/2024 10:22:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the ...

Earnings Scheduled For March 21, 2024
03/21/2024 10:15:14

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

Fennec Pharmaceuticals Q4 EPS $(0.10) Miss...
03/21/2024 10:02:07

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate...

Fennec Pharmaceuticals's Earnings Outlook
03/20/2024 17:01:46

Craig-Hallum Maintains Buy on Fennec Pharm...
03/18/2024 19:31:35

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

Reported Sunday, Fennec Pharmaceuticals An...
03/18/2024 06:06:21

Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI®, the first and only approve...

Fennec Pharmaceuticals Preliminary Report:...
02/29/2024 12:12:45

Fennec Pharmaceuticals Disclosed That The ...
02/01/2024 11:01:00

Fennec Pharma Announces Incremental $5M In...
12/05/2023 10:58:54

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company focused on improving th...

Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

Fennec Pharmaceuticals Says Cash And Cash ...
11/06/2023 11:06:49

Fennec Pharmaceuticals Q3 EPS $(0.07) Beat...
11/06/2023 11:05:21

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate o...

Preview: Fennec Pharmaceuticals's Earnings
11/03/2023 20:01:31

Stocks That Hit 52-Week Lows On Wednesday
10/04/2023 16:01:17

On Wednesday, 311 stocks hit new 52-week lows.

HC Wainwright & Co. Maintains Buy on Fenne...
08/04/2023 11:04:48

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the ...

Earnings Scheduled For August 3, 2023
08/03/2023 10:59:00

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on reven...

Fennec Pharmaceuticals Q2 EPS $(0.21) Miss...
08/03/2023 10:25:25

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate...

Analyst Ratings for Fennec Pharmaceuticals
06/21/2023 14:00:45

HC Wainwright & Co. Reiterates Buy on Fenn...
06/21/2023 11:26:25

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

Fennec Pharmaceuticals Announces European ...
06/06/2023 09:45:46

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company, today announced Pedmar...